Skip to main content
OpenTrials

Clinical trial condition

Influenza

Explore clinical trials studying Influenza. Study availability and eligibility vary by location and protocol.

1,207 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Influenza trial results

Completed

Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years

NCT00719043

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Chicago, Illinois, United States
  • GSK Investigational Site Metairie, Louisiana, United States
  • GSK Investigational Site Milford, Massachusetts, United States
View all 13 locations
View Trial Details
Completed

Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age

NCT01659086

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Edison, New Jersey, United States
  • GSK Investigational Site Austin, Texas, United States
  • GSK Investigational Site Sherbrooke, Quebec, Canada
View Trial Details
Completed

A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A Infection

NCT02293863

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • CHU St Pierre (St Pierre) Brussels, Belgium
  • Hospital Erasme; Neurologie Brussels, Belgium
  • UZ Leuven Gasthuisberg Leuven, Belgium
  • CHU UCL Mont-Godinne Mont-godinne, Belgium
View all 171 locations
View Trial Details
Completed

Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years

NCT00616928

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • GSK Investigational Site Huntsville, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Anaheim, California, United States
  • GSK Investigational Site Jacksonville, Florida, United States
View all 40 locations
View Trial Details
Completed

Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A

NCT00540592

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • GSK Investigational Site Güglingen, Baden-Wurttemberg, Germany
  • GSK Investigational Site Mannheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Rudersberg, Baden-Wurttemberg, Germany
  • GSK Investigational Site Weinheim, Baden-Wurttemberg, Germany
View all 30 locations
View Trial Details
Completed

Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults

NCT00529516

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • GSK Investigational Site Clearwater, Florida, United States
  • GSK Investigational Site Coral Gables, Florida, United States
  • GSK Investigational Site Milford, Massachusetts, United States
  • GSK Investigational Site Chaska, Minnesota, United States
View all 29 locations
View Trial Details

Related conditions